Cite
The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges
MLA
Jonaid Ahmad Malik, et al. “The SARS-CoV-2 Mutations versus Vaccine Effectiveness: New Opportunities to New Challenges.” Journal of Infection and Public Health, vol. 15, no. 2, Oct. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....827203f5324d600cf0e5f929eaa39255&authtype=sso&custid=ns315887.
APA
Jonaid Ahmad Malik, Sakeel Ahmed, Aroosa Mir, Mrunal Shinde, Onur Bender, Farhan Alshammari, Mukhtar Ansari, & Sirajudheen Anwar. (2021). The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges. Journal of Infection and Public Health, 15(2).
Chicago
Jonaid Ahmad Malik, Sakeel Ahmed, Aroosa Mir, Mrunal Shinde, Onur Bender, Farhan Alshammari, Mukhtar Ansari, and Sirajudheen Anwar. 2021. “The SARS-CoV-2 Mutations versus Vaccine Effectiveness: New Opportunities to New Challenges.” Journal of Infection and Public Health 15 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....827203f5324d600cf0e5f929eaa39255&authtype=sso&custid=ns315887.